Fidelity International’s SpringWorks Therapeutics SWTX Stock Holding History

Fidelity International’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,013,959	Closed	-$142M	–	1050
2025 Q2	$142M	Buy	+3,013,959	New	+$134M	0.12%	184

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fidelity International's SWTX Position: Q3 2025 in Review

Fidelity International sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 3,013,959 shares — an estimated $142M sold.

Fidelity International first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $142M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Fidelity International reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Fidelity International sold 3,013,959 SpringWorks Therapeutics shares in Q3 2025, an estimated $142M.
Fidelity International first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Fidelity International's SpringWorks Therapeutics position peaked at $142M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Fidelity International's 13F filing for Q3 2025, filed 13 Nov 2025.